跳至主要内容
临床试验/RBR-63czrx
RBR-63czrx尚未招募2 期

Effect of prebiotic and simbiotic supplementation on lipidic and glycemic profile, inflammatory markers and symptoms of depression and anxiety in individuals with diabetes mellitus type 1 and 2: randomized clinical trial, placebo-controlled and triple blind

niversidade Federal de Santa Catarina0 个研究点开始时间: 2018年1月19日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
19Y 至 90Y(—)

入选标准

  • Volunteers who are diagnosed with type 1 or type 2 diabetes mellitus; both genders; age above 19 years.

排除标准

  • Individuals with previous gastrointestinal diseases; previous gastrointestinal surgeries; intolerances or food allergies; use of anti-inflammatory drugs or antibiotics up to three months prior to study or during study; regular use of laxatives; use of opioid narcotic analgesics; use of appetite suppressants; current or previous use up to one month of probiotic symbiotic prebiotics or products enriched with these ingredients; presenting intolerance to prebiotics or probiotics or symbiotics; pregnant or lactating women; following a diet for weight loss or gain in the last three months; current follow-up of unusual diets; alcohol dependence; illicit drugs and smokers.

研究者

发起方
niversidade Federal de Santa Catarina

相似试验